Endocrine, metabolic & immune disorders drug targets

Keyphrases

Publications

2023

Alfredo Vozza, Erasmo Porfido, Alessandra Delvino, Carlo Custodero, Giuseppe Lisco, Vincenzo Triggiani, Cosimo Tortorella, Giuseppina Piazzolla
The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report. Endocrine, metabolic & immune disorders drug targets (2023)
Majdedin Ghalavand, Hadi Esmaeili Gouvarchin Ghaleh, Mostafa Khafaei, Mahdi Paryan, Bahman Jalali Kondori, Majid Mirzaei Nodoushan, Soheil Vazifedust, Samira Mohammadi-Yeganeh
Effect of calcitriol treated mesenchymal stem cells as an immunomodulation micro-environment on allergic asthma in a mouse model. Endocrine, metabolic & immune disorders drug targets (2023)
Mouna Nouar, Maroua Miliani, Imène Belhassena, Ahlam Fatmi, Mourad Aribi
Sodium selenite modulates global activation of proinflammatory M1-like macrophages, necroinflammation and M1-like/M2-like dichotomy at the onset of human type 1 diabetes. Endocrine, metabolic & immune disorders drug targets (2023)
Elsa Vitale, Rocco Mea, Angelo Benedetto, Donatella Capizzello, Zacchino Simone, Zaminga Melania, Matteo Russo, Filippo Ingrosso, Chiara Mazzarella, Scupola Giovanni Maria, Teresa Buccolieri, Roberto Lupo
Anxiety, Depression, Body Mass Index, Physical Activity in Nomophobic Italian nurses: a chronic latent inflammation? Endocrine, metabolic & immune disorders drug targets (2023)
Yue Liu, Hongchao Huang, Jianan Li, Kaihui Zhang, Hongfeng Jiang
CircRNA circPRKCI is upregulated in osteoporosis and sponges miR-103 to suppress the apoptosis of osteoblast induced by Lipopolysaccharide (LPS). Endocrine, metabolic & immune disorders drug targets (2023)
Maoyi Yang, Zhipeng Hu, Rensong Yue
Effects of Sheng-Mai Injection on Diabetes Mellitus: A Systematic Review and Meta-analysis. Endocrine, metabolic & immune disorders drug targets (2023)
Kirtika Madan, Sarvesh Paliwal, Swapnil Sharma, Seema Kesar, Neha Chauhan, Mansi Madan
Metabolic Syndrome: The Constellation of Co-morbidities, a Global Threat. Endocrine, metabolic & immune disorders drug targets (2023)
Xuan Qi, Ronghua Wang, Lu Jin, Yu Tian, Hongtao Jin, Yuxiang Han, Chao Sun, Meng Ding, Huifang Guo
MiR-223-3p aggravates ocular inflammation in Sjögren's syndrome. Endocrine, metabolic & immune disorders drug targets (2023)
Ting-Ting Shi, Hong-Ying Liu, Xiao-Rong Zhu, Zhong Xin, Lin Hua, Rong-Rong Xie, Ran Sun, Xi Cao, Jin-Kui Yang
Integrated proteomics and metabolomics analyses of serum in Chinese patients with severe and active Graves' orbitopathy: a cross-sectional study. Endocrine, metabolic & immune disorders drug targets (2023)
Heloisa de Faria Baltazar, Fernando Luiz Affonso Fonseca, Paula Midori Castelo, Beatriz da Costa Aguiar Alves, Thaís Gascón, Glaucia Luciano da Veiga, Edimar Cristiano Pereira
Use of Saliva to Assess the Adherence to Treatment with Oral Hypoglycemic Agents in Patients with Type 2 Diabetes. Endocrine, metabolic & immune disorders drug targets (2023)
Jemma Gregory, Benjamin Noble, Donna Ward, Zoe Wyrko, Luca Laghi
Admission avoidance for older adults facilitated by telemedicine during the COVID-19 pandemic. Endocrine, metabolic & immune disorders drug targets (2023)
Pratibha Pandey, Fahad Khan, Ramish Maqsood, Tarun Kumar Upadhyay
Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment. Endocrine, metabolic & immune disorders drug targets (2023)
Fei Luo, Siyin Han, Meng Xia, Zhenxing Chen, Peng Liu, Jiang Lin
Study on the Mechanism of Hydrolyzed Seawater Pearl Tablet in Treating Chronic Sleep Deprivation Mice Model. Endocrine, metabolic & immune disorders drug targets (2023)
Ifriqya Medila, Ikram Toumi, Aicha Adaika, Aya Amrani, Messaouda Riab, Ouafa Boudebia
The Effect of sub-chronic Linuron Exposure on Thyroid, Liver, and Kidney Function in Male Wistar Rats. Endocrine, metabolic & immune disorders drug targets (2023)
Luigi Santacroce, Angela Pia Cazzolla, Roberto Lovero, Vincenzo Brescia, Domenico Ciavarella, Francesca Spirito, Marica Colella, Massimo Bilancia, Lorenzo Lo Muzio, Francesca Di Serio
Neurosensory alterations and Interleukins Cascade in SARS-CoV-2 Infection - Results from a Retrospective Cohort of COVID-19 Inpatients. Endocrine, metabolic & immune disorders drug targets (2023)
Giuseppe Lisco, Sara Volpe, Domenico Triggiani, Vincenzo Triggiani, Giuseppina Piazzolla
When serum c-peptide measurement drives adequate diabetes mellitus diagnosis and therapy: a case report. Endocrine, metabolic & immune disorders drug targets (2023)
Bita Entezari, Deniz Bozdag, Hande Gurer-Orhan
Evaluation of Endocrine Related Adverse Effects of Non-Endocrine Targeted Pharmaceuticals in Cellular Systems. Endocrine, metabolic & immune disorders drug targets (2023)
Antara Banerjee, Sarubala Malayaperumal, Surajit Pathak
Healthy Aging: Perseverance to well being. Endocrine, metabolic & immune disorders drug targets (2023)
Xiangqun Deng, Ling Deng, Min Xu, Yanlei Sun, Mei Yang
Effects of SIRT1 on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Type 2 Diabetic Patients. Endocrine, metabolic & immune disorders drug targets (2023)
Ziqing Liao, Yanting Liang, Ye Wang, Chun Liang
Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes. Endocrine, metabolic & immune disorders drug targets (2023)
Tingting Wang, Hao Shen, Tingting Liu, Ting Zhao, Li Xu, Jie Feng, Huilan Zhang, Li Sun, Hongjian Li, Luhai Yu
The ABCB1 C3435T polymorphism is associated with triglyceride reduction in atorvastatin-treated Uygur patients with coronary heart disease and dyslipidemia: an observational study. Endocrine, metabolic & immune disorders drug targets (2023)
Yen-Po Lin, Yi-Chiung Hsu, Kun-Zhe Tsai, Younghoon Kwon, Gen-Min Lin
Insulin resistance indices and carotid intima-media thickness in physically fit adults: CHIEF Atherosclerosis Study. Endocrine, metabolic & immune disorders drug targets (2023)
Bhawna Chopra, Ashwani Kumar Dhingra
Therapeutic and Health Promoting Potential of Bakuchiol from Psoralea corylifolia: A Comprehensive Review. Endocrine, metabolic & immune disorders drug targets (2023)
Rui Feng, Zhongxing Li, Guangcheng Ge, Chenghao Wang, Yuejun Jia, Jun Ouyang
Cancer-associated fibroblast-derived extracellular vesicles mediate immune escape of bladder cancer via PD-L1/PD-1 expression. Endocrine, metabolic & immune disorders drug targets (2023)
Domenico Triggiani, Giuseppe Lisco
Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022). Endocrine, metabolic & immune disorders drug targets (2023)
Kok-Lun Pang, Kok-Yong Chin, Soelaiman Ima Nirwana
Immunomodulatory Effects of Agarwood Leaf Extract on RAW264.7 Murine Macrophages. Endocrine, metabolic & immune disorders drug targets (2023)
Munir Akhtar, Rubaida Mehmood, Mukhtar Hussain, Momna Warraich, Hafeez Ullah, Zahida Batool, Sumara Ashraf, Rida Sana
Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the Basis of Differences in Ethnicity and Curcumin as a Possible Treatment. Endocrine, metabolic & immune disorders drug targets (2023)
Xiuhong Lin, Lin Cheng, Yan Wan, Yuerong Yan, Zhuo Zhang, Xiaohui Li, Jiayun Wu, Xiaoyi Wang, Mingtong Xu
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β cells. Endocrine, metabolic & immune disorders drug targets (2023)
Giuseppe Lisco, Domenico Triggiani, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Giuseppina Piazzolla, Emilio Jirillo, Vincenzo Triggiani
Endocrine, Metabolic, and Immune Pathogenesis of Postmenopausal Osteoporosis. Is there a Therapeutic Role in Natural Products? Endocrine, metabolic & immune disorders drug targets (2023)
Rania H Ahmed, Rasha Rashad Ahmed, Sanaa R Galaly, Nadia Moustafa, Mohammed A S Abourehab, Mohamed A Abdelgawad, Osama M Ahmed, Manal Abdul-Hamid
Mesenchymal Stem Cells and Curcumin Effectively Mitigate Freund's Adjuvant-induced Arthritis via their Anti-inflammatory and Gene Expression of COX-1, IL-6 and IL-4. Endocrine, metabolic & immune disorders drug targets (2023)
Anton Lievykh, Volodymyr Zhyliuk, Galyna Ushakova, Victoriia Tkachenko, Yuliia Kovalchuk, Olena Dovban, Yuliia Kharchenko, Alla Shevtsova
Impact of Vitamin D3 on Carbonyl-Oxidative Stress and Matrix Metalloproteinases after Acute Intracerebral Hemorrhage in Rats with Type 2 Diabetes Mellitus. Endocrine, metabolic & immune disorders drug targets (2023)
Enrico Papini, Anna Crescenzi, Annamaria D'Amore, Maurilio Deandrea, Anna De Benedictis, Andrea Frasoldati, Roberto Garberoglio, Rinaldo Guglielmi, Celestino Pio Lombardi, Giovanni Mauri, Rosa Elisa Miceli, Soraya Puglisi, Teresa Rago, Domenico Salvatore, Vincenzo Triggiani, Dominique Van Doorne, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Michele Basile, Alessandro Scoppola, Agostino Paoletta, Agnese Persichetti, Irene Samperi, Renato Cozzi, Franco Grimaldi, Marco Boniardi, Angelo Camaioni, Rossella Elisei, Edoardo Guastamacchia, Giulio Nati, Tommaso Novo, Massimo Salvatori, Stefano Spiezia, Gianfranco Vallone, Michele Zini, Roberto Attanasio
Italian Guidelines For The Management Of Non-Functioning Benign And Locally Symptomatic Thyroid Nodules. Endocrine, metabolic & immune disorders drug targets (2023)
Hidetaka Hamasaki
High-intensity Interval Training in Patients with Type 2 Diabetes: A Perspective from Previous Systematic Reviews. Endocrine, metabolic & immune disorders drug targets (2023)
Pia Štrukelj Pahović, Martina Iulini, Ambra Maddalon, Valentina Galbiati, Erica Buoso, Marija Sollner Dolenc, Emanuela Corsini
In Vitro Effects of Bisphenol Analogs on Immune Cells Activation and Th Differentiation. Endocrine, metabolic & immune disorders drug targets (2023)
Hui Li, Chong Yin, Jingjia Li, Qian Huang, Ying Huai, Xiaohua Chu, Mili Ji, Ye Tian, Airong Qian, Danming Li
MiR-12200-5p Targets Multiple Members of Wnt Signaling Pathway to Inhibit Osteoblast Differentiation and Bone Formation. Endocrine, metabolic & immune disorders drug targets (2023)
Majdedin Ghalavand, Hadi Esmaeili Gouvarchin Ghaleh, Mostafa Khafaei, Mahdi Paryan, Bahman Jalali Kondori, Majid Mirzaei Nodoushan, Soheil Vazifedust, Samira Mohammadi-Yeganeh
Effect of calcitriol treated mesenchymal stem cells as an immunomodulation micro-environment on allergic asthma in a mouse model. Endocrine, metabolic & immune disorders drug targets (2023)
Aadil Javed, Gülseren Özduman, Sevda Altun, Doğan Duran, Dilan Yerli, Tilbe Özar, Faruk Şimşek, Kemal Sami Korkmaz
Mitotic kinase inhibitors as Therapeutic Interventions for Prostate Cancer: Evidence from In vitro Studies. Endocrine, metabolic & immune disorders drug targets (2023)
Surya K De
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun N-terminal Kinase Inhibitors for Treating the Liver Fibrotic Disorder. Endocrine, metabolic & immune disorders drug targets (2023)
Huan He, Dong Mei Li
One Case of Pituitary Stalk Interruption Syndrome associated with Liver Cirrhosis. Endocrine, metabolic & immune disorders drug targets (2023)
Kun-Zhe Tsai, Yen-Po Lin, Shiue-Wei Lai, Chia-Hsin Liu, Yun-Cheng Chang, Gen-Min Lin
Non-Insulin-Based Insulin Resistance Indices and Localized Periodontitis in Physically Active Young Male Adults: CHIEF Oral Health Study. Endocrine, metabolic & immune disorders drug targets (2023)
Gamze Akkus
Two Cases with 17-alpha Hydroxylase Deficiency Misdiagnosed as Primary Aldosteronism. Endocrine, metabolic & immune disorders drug targets (2023)
Yi-Ting Chou, Kai-Wen Chen, Pang-Yen Liu, Kun-Zhe Tsai, Yen-Po Lin, Gen-Min Lin
Hepatic and Systemic Inflammation for Left Ventricular Mass in Physically Fit Adults: CHIEF Heart Study. Endocrine, metabolic & immune disorders drug targets (2023)
Kimia Ahmadi, Fatemeh Asgharzadeh, Shadi Mohammadpour-Asl, Fatemeh Ayari, Fatemeh Rahbar, Morteza Motazakker, Shiva Roshan-Milani, Amin Abdollahzade Fard
In vitro Pretreatment with Zinc Alleviates the Adverse Effect of Tetrahydrocannabinol on Cultured Mouse Sertoli Cells: Role of Anti-apoptotic and Antioxidant Activities. Endocrine, metabolic & immune disorders drug targets (2023)
Subarnarekha Maitra, Debarati Bhattacharya, Souvik Paul, Payel Ghosh Chowdhury, Dipanjan Mandal, Pallab Kanti Haldar, Ashok Kumar Balaraman, Asis Bala
Programmed Cell Death Protein 1 (PD-1) in relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma. Endocrine, metabolic & immune disorders drug targets (2023)
Carlo Caiati, Emilio Jirillo
Transplantation of Mesenchymal Stem Cells as A New Approach for Cardiovascular Diseases: from Bench to Bedside: A Perspective. Endocrine, metabolic & immune disorders drug targets (2023)
Amanda Morgan, Daryl Ramai, Praneeth Bandaru, Stefano Crino, Antonio Facciorusso
Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors. Endocrine, metabolic & immune disorders drug targets (2023)
Darab Ghadimi, Regina Fölster-Holst, Christoph Röcken, Hans-Jürgen Kaatsch, Michael Ebsen, Regis Tournebize, Wilhelm Bockelmann
Endogenous ethanol-producing bacteria interference in pathogen-host crosstalk. Endocrine, metabolic & immune disorders drug targets (2023)
Yuyang Chen, Munire Aili, Fan Chen, Yu Gong, Xiaoju Chen, Lan Zhang
Drugs Targeting NLRP3 Inflammasome in the Treatment of Diabetic Bone Disorders. Endocrine, metabolic & immune disorders drug targets (2023)

volume 23, number 6, 2023

Mario Giosuè Balzanelli, Pietro Distratis, Rita Lazzaro, Van Hung Pham, Toai Cong Tran, Gianna Dipalma, Francesco Inchingolo, Emilio Maria Serlenga, Sergey Khachatur Aityan, Andrea Ballini, Kieu Cao Diem Nguyen, Ciro Gargiulo Isacco
The Anti-Viral Activity of Stem Cells: A Rational Explanation for their Use in Clinical Application. Endocrine, metabolic & immune disorders drug targets 23 (6) (2023)

volume 23, number 8, 2023

Danila De Vito
Thematic Issue: Endocrine, Metabolic and Immune Disorders: A Public Health Issue. Endocrine, metabolic & immune disorders drug targets 23 (8) (2023)